After years of struggling with hurdles such as generic competition and significantly lower-than-expected sales of its top meds, Acorda Therapeutics is hanging up the gloves with a $185 million deal to sell off its assets and a bankruptcy filing.
XEOMIN® (incobotulinumtoxinA) receives three new therapeutic indications in Australia
Merz Therapeutics Hosts Over 300 International Healthcare Professionals at its First Global “Merz Expert Connect Summit 2023”
Merz's Biologic Xeomin (incobotulinumtoxinA) Receives Approval in the U.S.
Allergan and Merz Pharma yesterday unveiled a $54.4 million settlement with a New York labor union for police officers to dismiss their suit (without any admission of guilt) related to the companies’ clamping down on about a dozen generic competitors for the Alzheimer’s drug Namenda.
FRANKFURT, Germany--(BUSINESS WIRE)--Today, Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, has been granted the use of XEOMIN® for the symptomatic treatment in children and adolescents aged 2 to 17 years and weighing ? 12 kg of chronic sialorrhea due to neurological / neurodevelopmental disorders on EU level.1 The national approvals of the country authorities involved will follow in the next weeks. The U.S. Food and Drug Administration granted approval in December 2020, and the Russian Federal Service for Surveillance in Healthcare in spring 2021.
Merz Therapeutics , a Merz Group company and a leader in neurotoxins, and Teijin Pharma Limited , the core company of Teijin Group 's health operations , today jointly announced that Teijin Pharma has been granted additional approval by the Japanese Ministry of Health, Labor and Welfare (MHLW) to market Xeomin ® (incobotulinumtoxinA) for intramuscular injection in 50, 100 or 200 units for the treatment of lower extremity spasticity.
Merz’ s Biolog Xeomin (incobotulinumtoxinA) Receive Supplemental Approval in US
The U.S. aesthetics business is booming. Fillers, fat freezers and the like are garnering interest and spurring marketing campaigns as plastic surgery and aestheticians' offices reopen after pandemic closures.